Evidence map›Paper›PMID 39275223›Full record

Trial reportNutrients2024

Matcha Does Not Affect Electroencephalography during Sleep but May Enhance Mental Well-Being: A Randomized Placebo-Controlled Clinical Trial.

Yoshitake Baba, Takanobu Takihara, Noritaka Okamura

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoshitake BabaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara 421-0516, Shizuoka, Japan.ORCID 0000-0002-3177-803X
Takanobu TakiharaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara 421-0516, Shizuoka, Japan.ORCID 0000-0002-3463-5237
Noritaka OkamuraDepartment of Medical Technology, Faculty of Health Sciences, Ehime Prefectural University of Health Sciences, 543 Takoda, Tobe-cho 791-2101, Iyo-Gun, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although theanine in matcha improves sleep quality and cognitive function, the caffeine in green tea is thought to worsen sleep quality. Therefore, this study investigated the factors behind the observed improvements in subjective sleep quality in matcha. A placebo-controlled randomized double-blind parallel-group study was conducted on healthy Japanese men and women aged 27-64 years. After 4 weeks of consuming 2.7 g of matcha daily (containing 50.3 mg theanine, 301.4 mg catechins, and 71.5 mg caffeine), no significant differences were observed between the control and matcha groups on total sleep time, sleep latency, wake after sleep onset, or sleep efficiency measured by electroencephalography (EEG). However, the sleep questionnaire Oguri-Shirakawa-Azumi Sleep Inventory, the Middle-age and Aged version (OSA-MA), administered immediately after waking showed a trend toward increased satisfaction with sleep time (

Indexed as

Mental HealthSleepTeaAdultCaffeineDouble-Blind MethodElectroencephalographyFemaleGlutamatesHumansMaleMiddle AgedSleep QualitySurveys and QuestionnairesCaffeineGlutamatesTeatheaninecaffeinedepressionEEGmatchasleep qualitytheanine

Identifiers

PMID39275223
PMCPMC11397442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.